Hepatitis B virus (HBV) is a para-retrovirus or retroid virus that contains a double-stranded
DNA genome and replicates this DNA via reverse transcription of a RNA pregenome. Viral …

Currently, despite the use of a preventive vaccine for several decades as well as the use of
effective and well-tolerated viral suppressive medications since 1998, approximately 250 …

Hepatitis B virus (HBV) remains a major medical problem affecting at least 257 million
chronically infected patients who are at risk of developing serious, frequently fatal liver …

As obligate intracellular parasites, viruses need a host cell to provide a milieu favorable to
viral replication. Consequently, viruses often adopt mechanisms to subvert host cellular …

With a yearly death toll of 880,000, hepatitis B virus (HBV) remains a major health problem
worldwide, despite an effective prophylactic vaccine and well-tolerated, effective antivirals …

Human hepatitis B virus (HBV) is a small enveloped DNA virus with a complex life cycle. It is
the causative agent of acute and chronic hepatitis. HBV can resist immune system …

Current therapies of chronic hepatitis B (CHB) remain limited to pegylated-interferon-alpha
(PegIFN-α) or any of the five approved nucleos (t) ide analogues (NUC) treatments. While …

Despite a preventive vaccine being available, more than 250 million people suffer from
chronic hepatitis B virus (HBV) infection, a major cause of liver disease and HCC. HBV …

The core (capsid) protein of hepatitis B virus (HBV) is the building block of nucleocapsids
where viral DNA reverse transcriptional replication takes place and mediates virus-host cell …

Hepatitis B virus is a member of the Hepadnaviridae family and responsible for causing
acute and chronic hepatitis in humans. The current estimates of people chronically infected …